ProMedEx Forms Saudi JV With Beijing Synapsor, SAR 35M Project
PRO MEDEX 9574.SA | 0.00 |
Professional Medical Expertise Company (ProMedEx) announced on July 14, 2026, the signing of a joint venture agreement with Beijing Synapsor Artificial Intelligence Co., Ltd. on July 13, 2026, to establish a limited liability company in Saudi Arabia under the name "PMX Syai Arabia Company," with a registered capital of SAR 1,000,000 — ProMedEx holding an 80% stake (SAR 800,000) and the Partner holding 20% (SAR 200,000). The joint venture will develop a manufacturing facility for single-use medical products and consumables, with a total estimated project cost of SAR 35,000,000 to be deployed in stages. Construction is expected to commence on August 23, 2026, with completion targeted for May 2027, followed by trial production in June 2027 and commercial production commencing approximately in August 2027. The financial impact of the project on the Company's statements is expected to be reflected by the end of the 2027 financial year, subject to obtaining the requisite regulatory approvals from relevant Saudi authorities.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=96773&anCat=1&cs=9574&locale=arImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.
